Dual Regulation of Silent and Productive Infection in Monocytes by Distinct Human Immunodeficiency Virus Type 1 Determinants

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 1992 Jun 1

PMID 1533883

Citations 57

Authors

P Westervelt

T Henkel

D B Trowbridge

J Orenstein

J Heuser

H E Gendelman

L Ratner

Affiliations

Soon will be listed here.

Abstract

The regulation of human immunodeficiency virus type 1 infection and replication in primary monocytes was investigated by mutagenesis of recombinant proviral clones containing an env determinant required for the infectivity of monocytes. Virus replication was assayed by determination of reverse transcriptase activity in culture fluids and by recovery of virus from monocytes following cocultivation with uninfected peripheral blood mononuclear cells. Three virus replication phenotypes were observed in monocytes: productive infection, silent infection, and no infection. Incorporation of the monocytetropic env determinant in a full-length clone incapable of infection or replication in primary monocytes (no infection) conferred the capacity for highly efficient virus replication in monocytes (productive infection). Clones with the env determinant but lacking either functional vpr or vpu genes generated lower replication levels in monocytes. Mutation of both vpr and vpu, however, resulted in nearly complete attenuation of virus replication in monocytes, despite subsequent virus recovery from infected monocytes by cocultivation with uninfected peripheral blood mononuclear cells (silent infection). These findings indicate a central role for the "accessory" genes vpu and vpr in productive human immunodeficiency virus type 1 replication in monocytes and indicate that vpu and vpr may be capable of functional complementation.

Citing Articles

HIV replication and latency in monocytes and macrophages.

Veenhuis R, Abreu C, Shirk E, Gama L, Clements J Semin Immunol. 2021; 51:101472.

PMID: 33648815 PMC: 10171083. DOI: 10.1016/j.smim.2021.101472.

TZM-gfp cells: a tractable fluorescent tool for analysis of rare and early HIV-1 infection.

Gludish D, Boliar S, Caldwell S, Tembo D, Chimbayo E, Jambo K Sci Rep. 2020; 10(1):19900.

PMID: 33199722 PMC: 7670428. DOI: 10.1038/s41598-020-76422-6.

Vpr Is a VIP: HIV Vpr and Infected Macrophages Promote Viral Pathogenesis.

Lubow J, Collins K Viruses. 2020; 12(8).

PMID: 32726944 PMC: 7472745. DOI: 10.3390/v12080809.

Vpr and Its Cellular Interaction Partners: R We There Yet?.

Fabryova H, Strebel K Cells. 2019; 8(11).

PMID: 31652959 PMC: 6912716. DOI: 10.3390/cells8111310.

Vpu Exploits the Cross-Talk between BST2 and the ILT7 Receptor to Suppress Anti-HIV-1 Responses by Plasmacytoid Dendritic Cells.

Bego M, Cote E, Aschman N, Mercier J, Weissenhorn W, Cohen E PLoS Pathog. 2015; 11(7):e1005024.

PMID: 26172439 PMC: 4501562. DOI: 10.1371/journal.ppat.1005024.

References

Adachi A, Gendelman H, Koenig S, Folks T, Willey R, Rabson A . Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol. 1986; 59(2):284-91. PMC: 253077. DOI: 10.1128/JVI.59.2.284-291.1986. View

Sodroski J, Goh W, Rosen C, Dayton A, Terwilliger E, Haseltine W . A second post-transcriptional trans-activator gene required for HTLV-III replication. Nature. 1986; 321(6068):412-7. DOI: 10.1038/321412a0. View

Gendelman H, Orenstein J, Martin M, Ferrua C, Mitra R, Phipps T . Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med. 1988; 167(4):1428-41. PMC: 2188914. DOI: 10.1084/jem.167.4.1428. View

Wong-Staal F, Chanda P, Ghrayeb J . Human immunodeficiency virus: the eighth gene. AIDS Res Hum Retroviruses. 1987; 3(1):33-9. DOI: 10.1089/aid.1987.3.33. View

Armstrong J, Horne R . Follicular dendritic cells and virus-like particles in AIDS-related lymphadenopathy. Lancet. 1984; 2(8399):370-2. DOI: 10.1016/s0140-6736(84)90540-3. View

Shioda T, Levy J, Cheng-Mayer C . Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature. 1991; 349(6305):167-9. DOI: 10.1038/349167a0. View

Westervelt P, Gendelman H, Ratner L . Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes. Proc Natl Acad Sci U S A. 1991; 88(8):3097-101. PMC: 51392. DOI: 10.1073/pnas.88.8.3097. View

Cohen E, Dehni G, Sodroski J, Haseltine W . Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J Virol. 1990; 64(6):3097-9. PMC: 249501. DOI: 10.1128/JVI.64.6.3097-3099.1990. View

OBRIEN W, Koyanagi Y, Namazie A, Zhao J, Diagne A, Idler K . HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature. 1990; 348(6296):69-73. DOI: 10.1038/348069a0. View

10.

Cohen E, Lu Y, Gottlinger H, Dehni G, Jalinoos Y, Sodroski J . The T open reading frame of human immunodeficiency virus type 1. J Acquir Immune Defic Syndr (1988). 1990; 3(6):601-8. View

11.

Sonigo P, Alizon M, Staskus K, Klatzmann D, Cole S, Danos O . Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus. Cell. 1985; 42(1):369-82. DOI: 10.1016/s0092-8674(85)80132-x. View

12.

Asjo B, Albert J, Biberfeld G, Karlsson A, Lidman K, Fenyo E . Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet. 1986; 2(8508):660-2. View

13.

Dedera D, Hu W, Heyden N, Ratner L . Viral protein R of human immunodeficiency virus types 1 and 2 is dispensable for replication and cytopathogenicity in lymphoid cells. J Virol. 1989; 63(7):3205-8. PMC: 250884. DOI: 10.1128/JVI.63.7.3205-3208.1989. View

14.

Heuser J . Effects of cytoplasmic acidification on clathrin lattice morphology. J Cell Biol. 1989; 108(2):401-11. PMC: 2115436. DOI: 10.1083/jcb.108.2.401. View

15.

Ratner L, Haseltine W, Patarca R, Livak K, Starcich B, Josephs S . Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature. 1985; 313(6000):277-84. DOI: 10.1038/313277a0. View

16.

Niederman T, Thielan B, Ratner L . Human immunodeficiency virus type 1 negative factor is a transcriptional silencer. Proc Natl Acad Sci U S A. 1989; 86(4):1128-32. PMC: 286639. DOI: 10.1073/pnas.86.4.1128. View

17.

Cheng-Mayer C, Seto D, Tateno M, Levy J . Biologic features of HIV-1 that correlate with virulence in the host. Science. 1988; 240(4848):80-2. DOI: 10.1126/science.2832945. View

18.

Fisher A, Feinberg M, Josephs S, Harper M, Marselle L, Reyes G . The trans-activator gene of HTLV-III is essential for virus replication. Nature. 1986; 320(6060):367-71. DOI: 10.1038/320367a0. View

19.

Gartner S, Markovits P, Markovitz D, Kaplan M, Gallo R, Popovic M . The role of mononuclear phagocytes in HTLV-III/LAV infection. Science. 1986; 233(4760):215-9. DOI: 10.1126/science.3014648. View

20.

Koenig S, Gendelman H, Orenstein J, Dal Canto M, Pezeshkpour G, Yungbluth M . Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science. 1986; 233(4768):1089-93. DOI: 10.1126/science.3016903. View